文献速递关节外科

抑郁治疗与全关节置换术后患者报告结局改善无关

Depression Treatment Is Not Associated With Improved Patient-Reported Outcomes Following Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2019-08-09

本研究旨在探究接受治疗与未接受治疗的抑郁患者在全关节置换术后疾病特异性、整体健康和活动结局方面是否存在差异。研究将接受初次择期单侧全关节置换术的患者按抑郁病史及治疗状态分为无抑郁、抑郁已治疗和抑郁未治疗三组,主要结局为术后12个月内SF-12 PCS、SF-12 MCS、WOMAC和UCLA活动评定量表的变化。结果显示,在控制潜在混杂因素后,抑郁患者无论是否接受治疗,术后12个月评估结局的绝对评分或净变化均无差异(P > .05),抑郁治疗并未减轻抑郁对全关节置换术结局的负面影响。

要点

  • 抑郁患病率为189/749(25%)。
  • 控制混杂因素后,抑郁患者无论是否治疗,术后12个月各结局评分及净变化均无差异(P > .05)。
  • 抑郁治疗未影响患者对活动受限的感知(P = .412)。

核心结论

  • 尽管抑郁明确对初次全关节置换术患者结局产生不利影响,但抑郁治疗似乎并未减轻这一负面影响。
  • 抑郁治疗并不必然意味着抑郁症状的缓解。
  • 未来研究应探索替代干预措施以减少抑郁相关的健康后果,从而优化全关节置换术的结局。

研究设计与样本

  • 本研究为观察性研究,纳入接受初次、择期、单侧全关节置换术的患者。
  • 根据手术时自报的抑郁病史及治疗情况将患者分为三组:无抑郁组、抑郁已治疗组和抑郁未治疗组。
  • 主要结局为术后至12个月时SF-12 PCS、SF-12 MCS、WOMAC和UCLA活动评定量表的差异。
  • 次要结局为抑郁治疗对患者感知因抑郁导致活动受限的影响。
  • 采用单变量和混合效应模型分析以控制潜在混杂因素。

主要发现

  • 抑郁患病率为189/749(25%)。
  • 与抑郁已治疗组相比,抑郁未治疗组基线SF-12 MCS较低(P < .001),且更可能拥有Medicaid保险(P < .001)。
  • 控制潜在混杂因素后,抑郁患者无论是否接受治疗,术后12个月评估结局的绝对评分或净变化均无差异(P > .05)。
  • 抑郁治疗未影响患者对活动受限的感知(P = .412)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to investigate if there were differences in disease-specific, overall health, and activity outcomes after total joint arthroplasty (TJA) between treated and untreated depressed patients. METHODS: Patients who underwent primary, elective, unilateral TJA were divided into 3 groups based on self-reported history of depression and treatment at the time of surgery: 1) patients without depression, 2) patients with treated depression, and 3) patients with untreated depression. The primary outcomes were the differences in SF-12 PCS, SF-12 MCS, WOMAC, and UCLA activity rating scale up to 12 months postoperatively. A secondary outcome was the effect of depression treatment on patients' perception of experiencing limitation in their activities due to depression. Univariate and mixed-effects model analyses were performed to control for potential confounding factors. RESULTS: The prevalence of depression was 189/749 (25%). Compared to patients with treated depression, untreated patients had lower baseline SF-12 MCS (P < .001) and were more likely to have Medicaid insurance (P < .001). After controlling for potential confounding factors, there were no differences in either the absolute scores or net changes in any of the assessed outcomes at 12 months postoperatively among depressed patients regardless of treatment (P > .05). In addition, depression treatment did not affect patients' perception of activity limitation (P = .412). CONCLUSION: Although it is clear that depression adversely impacts patient outcomes in primary TJA, treatment does not appear to mitigate this negative effect. Depression treatment does not necessarily imply resolution of depressive symptoms. Future studies should explore alternative interventions to reduce the health-related consequences of depression to optimize the outcomes of TJA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Halawi MJ, Gronbeck C, Savoy L, et al. Depression Treatment Is Not Associated With Improved Patient-Reported Outcomes Following Total Joint Arthroplasty. J Arthroplasty. 2019. PMID: 31495530. doi:10.1016/j.arth.2019.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。